4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics
04 janv. 2022 08h04 HE
|
4Bio Capital
Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...
4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics
04 janv. 2022 08h03 HE
|
4Bio Capital
Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...
4BIO Capital Announces Strategic Partnership with Harbor Capital Advisors
02 déc. 2021 09h04 HE
|
4Bio Capital
4BIO Capital Announces Strategic Partnership with Harbor Capital Advisors 4BIO Capital appointed as highly specialized asset manager for Harbor’s disruptive innovation strategy after competitive...
4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics
20 avr. 2021 09h00 HE
|
4Bio Capital
Press Release 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 20 April 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital...
4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round
01 mars 2021 08h08 HE
|
4Bio Capital
Press Release 4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round 1 March 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”),...
4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery
25 janv. 2021 07h00 HE
|
4Bio Capital
Press Release 4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery Systematic review and meta-analysis of 149 clinical trials of AAV-based gene...
Appointment of Professor Akiko Iwasaki to Scientific Advisory Board
18 déc. 2020 07h00 HE
|
4Bio Capital
Appointment of Professor Akiko Iwasaki to Scientific Advisory Board Professor of Molecular, Cellular and Developmental Biology and Immunology at Yale UniversityPrincipal investigator at the Howard...
Appointment of Professor Akiko Iwasaki to Scientific Advisory Board
18 déc. 2020 02h00 HE
|
4Bio Capital
Appointment of Professor Akiko Iwasaki to Scientific Advisory Board Professor of Molecular, Cellular and Developmental Biology and Immunology at Yale UniversityPrincipal investigator at the Howard...
4BIO Capital leads SparingVision’s €44.5 million financing round
21 oct. 2020 07h00 HE
|
4Bio Capital
Press Release 4BIO Capital leads SparingVision’s €44.5 million financing round 21 October 2020 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...
4BIO Capital leads SparingVision’s €44.5 million financing round
21 oct. 2020 01h00 HE
|
4Bio Capital
Press Release 4BIO Capital leads SparingVision’s €44.5 million financing round 21 October 2020 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...